Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

GermanyBack to Germany

Clinical trials in Neumarkt in der Oberpfalz

2 clinical trials in Neumarkt in der Oberpfalz, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Neumarkt in der Oberpfalz at a glance
2
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

2 trials in Neumarkt in der Oberpfalz

Open in trial search

Malignant peritoneal neoplasm+2

Recruiting
Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:AGO Research GmbH

Hormone receptor positive breast cancer+2

Recruiting
Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:Institut fuer Frauengesundheit GmbH

Other cities in Germany

The busiest research cities in the country

All 515 cities in Germany

Clinical research in Neumarkt in der Oberpfalz

What the registry says about research in the country

01 Neumarkt in der Oberpfalz
Oncology and Neoplasms
Clinical research in Neumarkt in der Oberpfalz is focused on cancer, with studies centered on advanced breast cancer and gynecologic cancers. The trials are exploring better ways to improve disease control and support longer survival for people with hard-to-treat tumors. Advanced HER2-negative, hormone receptor-positive breast cancer Newly diagnosed advanced ovarian cancer, peritoneal cancer, and fallopian tube cancer Assessment of progression-free survival and overall survival Comparing treatment strategies that include targeted therapy and anti-cancer combinations These studies aim to evaluate treatment effectiveness and refine care for patients with advanced disease, helping researchers better understand which approaches may offer the greatest benefit.
Breast Cancer Research
One line of research in oncology is examining treatment response in advanced breast cancer. The goal is to better understand how to improve outcomes for patients whose tumors do not express HER2 but do show hormone receptor positivity. Advanced HER2-negative and HR-positive breast cancer Study of treatment benefit in the first-line setting Focus on survival outcomes and disease control Research into factors linked to treatment resistance This work is intended to help identify more effective options for patients starting therapy for advanced breast cancer.
Gynecologic Oncology
Another trial area covers advanced ovarian and related gynecologic cancers. Researchers are comparing treatment approaches to see whether they can improve the time patients remain free from disease progression. Ovarian cancer, peritoneal cancer, and fallopian tube cancer Patients with newly diagnosed, advanced-stage disease Evaluation of chemotherapy combined with targeted treatment Measurement of progression-free survival as a main outcome The research is designed to guide treatment choices for newly diagnosed patients with advanced gynecologic malignancies.
Back to GermanyAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.